Risk factors associated with adverse events in neonates with peripherally inserted central catheter
Peripherally inserted central catheters have become a priority in infants who require long-term intravenous therapy, but their use involves certain risks. The aim of the study was to describe the occurrence of adverse events in newborns with peripherally inserted central catheters and to determine t...
Saved in:
Published in | Enfermería Intensiva (English ed.) Vol. 30; no. 4; pp. 170 - 180 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier España, S.L.U
01.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Peripherally inserted central catheters have become a priority in infants who require long-term intravenous therapy, but their use involves certain risks.
The aim of the study was to describe the occurrence of adverse events in newborns with peripherally inserted central catheters and to determine the risk factors associated with them.
A descriptive cross-sectional study was designed and performed. All neonates with peripherally inserted central catheters from October 1st, 2014 to September 30th, 2015 were included. The adverse events and sociodemographic and clinical variables related to neonates and analysed catheters were recorded.
A total of 140 catheters were placed in 116 infants. All of them were analysed. Adverse events occurred in 16.4%: catheter-associated bacteraemia (5.7%), obstruction (5.7%), extravasation (2.1%) and phlebitis (2.1%), <27 weeks of pregnancy (OR=1.2, p=.02), birth weight <1000g (OR=6.7, p=.02), with catheters in situ for longer than one week (OR=9.8, p=.02) and with perfusion of antibiotics per catheter (OR=1.3, p<.01). Phlebitis is associated with the insertion of the catheter in LL and head (OR=1.1, p=.03). Factors associated with bacteraemia risk with adjusted prevalence odds ratio are extremely low birth weight neonates (OR=6.38; p=.03) and with a catheter in situ for longer than one week (OR=9.41; p=.04).
The periodic evaluation of catheter-related adverse events is very useful to prepare improvement plans. This will maximise safety for the most vulnerable newborns, especially those of extremely low birth weight that require very long treatments.
Los catéteres centrales de inserción periférica se han convertido en una prioridad en los neonatos que necesitan terapia intravenosa de larga duración, pero su uso no está exento de riesgos.
Describir la aparición de eventos adversos en neonatos portadores de catéteres venosos centrales de inserción periférica y determinar factores de riesgo asociados a ellos.
Se llevó a cabo un estudio descriptivo transversal en el que se incluyeron la totalidad de neonatos portadores de catéteres venosos centrales de inserción periférica desde el 1 de octubre de 2014 hasta el 30 de septiembre de 2015. Se registraron los eventos adversos y variables sociodemográficas y clínicas relacionadas con los neonatos y los catéteres analizados.
Se incluyeron en el estudio un total de 116 neonatos y 140 catéteres. Se registraron eventos adversos en el 16,4% de ellos: bacteriemia asociada al catéter (5,7%), obstrucción (5,7%), extravasación (2,1%) y flebitis (2,1%). Los factores asociados a bacteriemia con el odds de prevalencia corresponde a neonatos: <27semanas de gestación (OR=1,2; p=0,02), con peso <1.000g (OR=6,7; p=0,02), portadores de catéter >1semana (OR=9,8; p=0,02) y con perfusión de antibióticos por catéter (OR=1,3; p<0,01). La flebitis se asocia con la inserción del catéter en miembros inferiores y cabeza (OR=1,1; p=0,03). Los factores asociados a bacteriemia con odds de prevalencia ajustada corresponde a neonatos de peso extremo (OR=6,38; p=0,03) y portadores del catéter >7días (OR=9,41; p=0,04).
La evaluación periódica de eventos adversos relacionados con catéteres es de gran utilidad para elaborar planes de mejora. Esto permitirá extremar la seguridad en los RN más vulnerables, en especial los neonatos con extremo bajo peso que precisan tratamientos muy prolongados. |
---|---|
ISSN: | 2529-9840 2529-9840 |
DOI: | 10.1016/j.enfie.2018.10.005 |